Stem Cell Company Stocks 10/18/09

The DOW broke a 10000 last week and has been rolling along much of 2009. Most of the large cap stem cell stocks have followed the market the past two weeks, but the others have moved sporadically. The sector is still looking for a catalyst.

Top Stem Cell Stock Performer(s) the Last Two Weeks:

- ThermoGenesis (KOOL) = Up 11%; KOOL's been trading in a tight range for 8 or 9 months. It has broke out yet, but it's worth keeping an eye on it.

Worst Stem Cell Stock Performer(s) the Last Two Weeks:

- Bioheart Inc. (BHRT.OB) = Down -38%; This stock spiked at the beginning of September and has fallen ever since. Based on the chart, the fall isn't done.

Stem Cell Stocks Current Price and % Up or Down 10/05/09 - 10/16/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $2.20; Up 8%
Aastrom Biosciences (ASTM) = Cur Price: $0.36; Down -13%
BioTime, Inc. (BTIM) = Cur Price: $4.66; Down -14%

Celgene Corp (CELG) = Cur Price: $56.42; Up 4%

Cytori Therapeutics (CYTX) = Cur Price: $3.69; Up 1%
Geron Corp (GERN) = Cur Price: $6.50; Up 3%
ThermoGenesis (KOOL) = Cur Price: $0.689; Up 11%
Osiris Therapeutics (OSIR) = Cur Price: $7.03; Up 8%
StemCell Inc. (STEM) = Cur Price: $1.60; Up 3%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.119; Up 5%
Athersys Inc. (ATHX) = Cur Price: $1.16; Up 2%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.278; Down -13%
Bioheart Inc. (BHRT.OB) = Cur Price: $1.15; Down -38%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.006; Down -23%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $2.14; Down -3%
Neuralstem (CUR) = Cur Price: $1.54; Up 6%
International Stem Cell (ISCO.OB) = Cur Price: $0.72; Up 3%
MultiCell Technologies (MCET.OB) = Cur Price: $0.021; Down -9%
Pluristem Therapeutics (PSTI) = Cur Price: $1.14; Down -15%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.175; Down -27%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.0025; Down -24%


Catalyst(s):

Still, nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key.

Stem Cell Company Stocks 10/4/09

The overall market is going through a bit of a correction after an unsustainable series of up days. The stem cell stocks have been hit just like the rest of the market. There still has been no real spark in the sector.

Top Stem Cell Stock Performer(s) the Last Two Weeks:

- Cord Blood America Inc. (CBAI.OB) = Up 152%; This move was caused by a combination of technicals and a series of news releases. This happens periodical with this stock. It looks like the fade has already begun.

Worst Stem Cell Stock Performer(s) the Last Two Weeks:

- Neurostem Inc. (CUR) = Down -22%; This stock is just retracing from a quick double a couple of weeks back. The fall happens to be just as fast the rise. Stay away.

Stem Cell Stocks Current Price and % Up or Down 9/21/09 - 10/2/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $2.03; Down -19%
Aastrom Biosciences (ASTM) = Cur Price: $0.414; Down -2%
BioTime, Inc. (BTIM) = Cur Price: $5.45; Up 21%

Celgene Corp (CELG) = Cur Price: $54.00; Up 3%

Cytori Therapeutics (CYTX) = Cur Price: $3.66; Up 3%
Geron Corp (GERN) = Cur Price: $6.31; Down -15%
ThermoGenesis (KOOL) = Cur Price: $0.62; Down -4%
Osiris Therapeutics (OSIR) = Cur Price: $6.53; Down -18%
StemCell Inc. (STEM) = Cur Price: $1.55; Down -11%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.113; Down -12%
Athersys Inc. (ATHX) = Cur Price: $1.14; Up 9%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.32; Up 16%
Bioheart Inc. (BHRT) = Cur Price: $1.85; Down -12%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0078; Up 152%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $2.20; Up 5%
Neuralstem (CUR) = Cur Price: $1.45; Down -22%
International Stem Cell (ISCO.OB) = Cur Price: $0.70; Down -19%
MultiCell Technologies (MCET.OB) = Cur Price: $0.023; Up 5%
Pluristem Therapeutics (PSTI) = Cur Price: $1.34; Up 3%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.24; Down -4%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.0033; Up 18%


Catalyst(s):

Still, nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key.